Introduction
Heterozygous familial hypercholesterolemia (heFH) - Overview
Heterozygous familial hypercholesterolemia (heFH) - Therapeutics Development
Heterozygous familial hypercholesterolemia (heFH) - Therapeutics Assessment
Heterozygous familial hypercholesterolemia (heFH) - Companies Involved in Therapeutics Development
Heterozygous familial hypercholesterolemia (heFH) - Drug Profiles
Heterozygous familial hypercholesterolemia (heFH) - Dormant Projects
Heterozygous familial hypercholesterolemia (heFH) - Discontinued Products
Heterozygous familial hypercholesterolemia (heFH) - Product Development Milestones
Appendix

List of Tables
Number of Products under Development for Heterozygous familial hypercholesterolemia (heFH), H1 2020
Number of Products under Development by Companies, H1 2020
Products under Development by Companies, H1 2020
Number of Products by Stage and Target, H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Heterozygous familial hypercholesterolemia (heFH) - Pipeline by AD Pharmaceuticals Co Ltd, H1 2020
Heterozygous familial hypercholesterolemia (heFH) - Pipeline by Beijing Mabworks Biotech Co Ltd, H1 2020
Heterozygous familial hypercholesterolemia (heFH) - Pipeline by Daewoong Co Ltd, H1 2020
Heterozygous familial hypercholesterolemia (heFH) - Dormant Projects, H1 2020
Heterozygous familial hypercholesterolemia (heFH) - Discontinued Products, H1 2020

List of Figures
Number of Products under Development for Heterozygous familial hypercholesterolemia (heFH), H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products by Top 10 Targets, H1 2020
Number of Products by Stage and Top 10 Targets, H1 2020
Number of Products by Top 10 Mechanism of Actions, H1 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2020
Number of Products by Top 10 Routes of Administration, H1 2020
Number of Products by Stage and Top 10 Routes of Administration, H1 2020
Number of Products by Top 10 Molecule Types, H1 2020
Number of Products by Stage and Top 10 Molecule Types, H1 2020

Companies Mentioned
• AD Pharmaceuticals Co Ltd
• Beijing Mabworks Biotech Co Ltd
• Daewoong Co Ltd
• Innovent Biologics Inc
• Madrigal Pharmaceuticals Inc
• NeuroBo Pharmaceuticals Inc
• Novartis AG
• Regeneron Pharmaceuticals Inc
• Zhejiang Hisun Pharmaceutical Co Ltd